Blood levels of selected hormones in patients with multiple sclerosis

Medical Science Monitor

Volumn 7, Issue 5, 2001, Pages 1005-1012

  Zych Twardowska, Elzbieta ^a,b   Wajgt, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b NONE   (Poland)

Author keywords

Analysis; Hormones; Multiple sclerosis

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOPHYSIS FUNCTION; LIOTHYRONINE BLOOD LEVEL; MALE; MULTIPLE SCLEROSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; THYROXINE METABOLISM;

ADULT; AGED; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PITUITARY HORMONES; RADIOIMMUNOASSAY; THYROXINE; TRIIODOTHYRONINE;

EID: 0034803348     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Multiple sclerosis: Some possible therapeutic opportunities
2. Serum prolactin and sex hormone concentrations in patientnts with multiple sclerosis
3. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
4. The neuroendocrine-immune axis
5. Hormones, lymphohemopoietic cytokines and the neuroimmune axis
6. CRH and the immune system
7. Immunomodulation of peripheral lymphocytes by hormones of the hypothalamus-pituitary-thyroid axis
8. Changes in T-cell subpopulations in multiple sclerosis
9. Multiple sclerosis and other immunologic diseases
10. CD4+ T cell activation in multiple sclerosis
11. Autoantibodies to pituitary corticotropin-producing cells: Possible markers for unfavourable outcome after pituitary microsurgery for Cushing's disease
12. Beta-adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: A regulatory role for cortisol and interleukin-1
13. Immunoreactive growth hormone (GH) secreted by human lymphocytes: Augmented release by exogenous GH
14. Sex steroids, glucocorticoids, stress and autoimmunity
15. ACTH production by human mononuclear cells
16. Interactions between the neuroendocrine and immune systems: Common hormones and receptors
17. CD8+ high CD11b+ low T cells (T suppressor-effectors) in multiple sclerosis cerebrospinal fluid are increased during high dose corticosteroid treatment
18. Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis
19. Thyroid function in patients with multiple sclerosis
20. Thyroid function in multiple sclerosis
21. Endocrine function in multiple sclerosis
22. Autoimmunity in multiple sclerosis
23. Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis
24. Antithyroid antibodies in multiple sclerosis
25. New diagnostic criteria for multiple sclerosis: Guideline for research protocols
26. Alterations in thyroid function in patients with systemic illness: The 'euthyroid sick syndrome'
27. Reciprocal cheges in serum concentrations of 3, 3′, 5′ trijodothyronine (T3) in systemic illness
28. Hyperprolactinemia in multiple sclerosis
29. Familial occurence of multiple sclerosis with thyroid disease and systemic lupus etythematosus
30. Multiple sclerosis and Hashimoto's thyroiditis
31. Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders. Report of 5 cases
32. Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test
33. Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses
34. Adrenal function after corticosreroid treatment in MS
35. Recovery of the hypothalamic-pituitary-adrenal axis from suppression by short-term, high-dose intravenous prednisolone therapy in patients with MS
36. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis
37. Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis
38. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone
39. The current therapy of multiple sclerosis
40. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined deramethasone-CRH test in multiple sclerosis
41. ACTH w osoczu i plynie mózgowo-rdzeniowym chorych na stwardnienie rozsiane
42. Dexamethasone suppression test abnormalities in multiple sclerosis: Relation to ACTH therapy
43. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function
44. Multiple sclerosis and the evolution of growth hormone mechanisms in man
45. Hormon wzrostu w surowicy krwi i plynie mózgowo-rdzeniowym chorych na stwardniene rozsiane
46. Autoantibodies in sera from patients with multiple sclerosis directed against antigenic determinants in pituitary growth hormone-secreting cells and in structures containing vasopressinloxytocin
47. Growth hormone deficiency and hypogonadism in a patient with multiple sclerosis
48. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-1
49. Effects of human growth hormone on immune functions: In vitro studies on cells of normal and growth hormone-deficient children
50. Growth hormone, lymphocytes and macrophages
51. Growth hormone treatment stimulates thymulin production in aged dogs